Literature DB >> 3911714

Treatment of severe Graves' ophthalmopathy with cyclosporin A.

C Utech, K G Wulle, E U Bieler, P Pfannenstiel, N Panitz, H Kiefer.   

Abstract

Ten patients with severe Graves' ophthalmopathy, resistant to other therapeutic regimens were treated with cyclosporin A (CyA) over a period of 6 months. Clinically, 9 patients improved, 2 of them only after addition of corticosteroids. Intra-ocular tension on upward gaze decreased in all of these 9 patients (P less than 0.01). In 6 patients there was a significant decrease in eye muscle thickness under the treatment (P less than 0.05) as determined by computerized tomography. Side effects (e.g., paraesthesia, proteinuria) which were observed under higher doses of CyA, disappeared after lowering the dose. In only one out of 3 patients with hypertension an antihypertensive medication became necessary. CyA appears to be a valuable drug for treatment of severe Graves' ophthalmopathy when previous therapeutic regimens turned out to be unsuccessful.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3911714     DOI: 10.1530/acta.0.1100493

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  2 in total

Review 1.  Immunosuppressant therapy of thyroid eye disease.

Authors:  G Kahaly; J Beyer
Journal:  Klin Wochenschr       Date:  1988-11-01

2.  Long-term observation of endocrine ophthalmopathy and retrospective appraisal of therapeutic measures.

Authors:  G Kahaly; H Böckmann; J Beyer; S Bischoff
Journal:  J Endocrinol Invest       Date:  1990-04       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.